Labcorp Holdings Inc. LH
309.64
0.69
0.22%
as of 25 Sep
- Market cap
- $21.9B
- P/E
- 25.4×
Follow LH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Labcorp Holdings Inc. (LH) P/S ratio
As of 25 September 2026, Labcorp Holdings Inc. (LH) trades at a P/S ratio of 1.8×. Over the past ten years it has ranged from 0.8× (March 2020) to 2.0× (December 2021); the current reading is higher than 98% of that period. That is below the Diagnostics & Research industry median of 4.9× and below the Healthcare sector median of 3.8×.
P/S ratio, daily
Annual
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.5× | 1.16% |
| FY2024 | 1.5× | (11.20%) |
| FY2023 | 1.7× | 6.18% |
| FY2022 | 1.6× | (21.06%) |
| FY2021 | 2.0× | 63.25% |
| FY2020 | 1.2× | (1.15%) |
| FY2019 | 1.2× | 26.78% |
| FY2018 | 1.0× | (29.88%) |
| FY2017 | 1.4× | 16.42% |
| FY2016 | 1.2× | (1.60%) |
Quarterly
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 1.6× | 2.70% |
| Mar 2026 | 1.6× | 3.77% |
| Dec 2025 | 1.5× | (13.67%) |
| Sep 2025 | 1.7× | 6.73% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.8×
High 2.0×
Ten-year median
1.4×
Current reading's percentile
98
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| ICLR ICON PLC compare | 1.6× |
| LH Labcorp Holdings Inc. | 1.8× |
| DGX Quest Diagnostics Incorporated compare | 2.3× |
| CRL Charles River Laboratories International, Inc. compare | 3.5× |
| RVTY Revvity Inc. compare | 5.8× |
| MEDP Medpace Holdings, Inc. compare | 6.3× |
| MTD Mettler-Toledo International, Inc. compare | 7.4× |
| GH Guardant Health, Inc. compare | 19.9× |
| TWST Twist Bioscience Corporation compare | 26.5× |
| Diagnostics & Research industry median | 4.9× |
| Healthcare sector median | 3.8× |
| Market median | 2.0× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on LH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement